retatrutide phase 2 diabetes trial A new weight-loss drug called is generating excitement after clinical participants lost an average of 30% of their body weight, results that rival or even exceed weight-loss surgery. Researchers also There's a new drug in

of 28 studies involving 304,060 individuals with 481 documented aspiration cases found that GLP-1 RA exposure was not associated with increased pulmonary aspiration (odds ratio 1.04, 95% confidence interval 0.871.25) despite a significant association with retained gastric contents (odds ratio 5.96, 95% confidence interval 3.968.98) [38]

Long-term electrolyte management Electrolyte needs change as your GLP-1 treatment progresses

Surgical options are also available and may be especially beneficial in those patients who are metabolically at risk, are severely obese and have been unsuccessful with more conservative management, Anton said

in Chemistry at the University of Arizona, Tucson, AZ, where he worked with Prof

Furthermore, in monogenic obesity (1% of total cases of obesity), the PCSK1 gene encoding the PC1/3 enzyme losses its function, or it is mutated [277]